SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Mannkind Corporation
An SI Board Since October 2013
Posts SubjectMarks Bans Symbol
84 9 0 MNKD
Emcee:  Guy Gadois Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Savant-1/26/2015
8MNKD D [graphic]TREND1-11/5/2014
7MannKind Corporation Reports 2014 Third Quarter Financial Results - Savant-11/3/2014
6 Mannkind announced closing of global licensing agreement with SanofiSavant-9/25/2014
5MannKind: Why Jefferies Says Buy -- Barron's Blog Aug 27, 2014 15:55:00 (Savant-8/27/2014
4MannKind Corporation: Back To The Fundamentals seekingalpha.comJulius Wong-8/20/2014
3 Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(Savant-8/11/2014
2VALENCIA, Calif., June 27, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (NasdaqSavant-6/28/2014
1FDA approval/no good deed goes unpunished...$11 down to $8.20, back to $10 ClassSavant-6/28/2014
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News